Germany’s Bundestag has approved a healthcare reform bill designed to strengthen the financial stability of the country’s statutory health insurance system and help contain rising healthcare costs.
The legislation introduces a package of measures aimed at reducing spending while maintaining access to medical services. The reforms include higher mandatory rebates from pharmaceutical companies, tighter controls on hospital expenditure and adjustments to healthcare reimbursement mechanisms.
According to the German government, the objective is to stabilize public health insurance finances without introducing broad reductions in healthcare services. Officials say the reform is intended to ease the financial burden on both employees and employers while ensuring the long-term sustainability of the system.
Representatives of the pharmaceutical industry have criticized parts of the legislation, arguing that stricter pricing measures could discourage investment and slow medical innovation in Germany.
The bill will now continue through the legislative process before the new measures can take effect.
